Cystatin C in cardiac surgery.

Area of Science:

• Nephrology
• Cardiology
• Biomarkers

Background:

• Glomerular filtration rate (GFR) assessment is crucial for managing patients with kidney disease.
• Cystatin C is a proposed alternative marker for GFR, offering potential advantages over traditional markers.
• Coronary artery bypass graft (CABG) surgery involves significant physiological stress that can impact renal function.

Purpose of the Study:

• To compare the efficacy of cystatin C and creatinine in estimating GFR during and after cardiopulmonary bypass in CABG patients.
• To evaluate the reliability of cystatin C as an alternative GFR marker in this specific surgical context.

Main Methods:

• Prospective study involving 49 patients undergoing CABG with normal preoperative renal function.
• Blood samples collected at 7 time points up to 72 hours postoperatively for creatinine and cystatin C assays.
• GFR estimated using Cockcroft and Gault formula for creatinine clearance and Larsson equation for cystatin C clearance.

Main Results:

• Both cystatin C and creatinine concentrations remained comparable throughout the study period, including during cardiopulmonary bypass and postoperatively.
• Estimated GFR calculated from both markers showed similar trends and values.
• Baseline values for both markers were within normal ranges.

Conclusions:

• Serum creatinine is a practical, cost-effective, and reliable marker for monitoring renal function in patients undergoing CABG surgery.
• Cystatin C does not offer a significant advantage over creatinine for GFR estimation in this patient population.
• Standard creatinine measurements suffice for assessing renal function in patients with normal preoperative kidney function undergoing CABG.